VA
BioAffinity Technologies' Lung Cancer Test Added to Federal Supply Schedule
The laboratory-developed test analyzes self-collected sputum samples treated with a fluorescent compound.
Foundation Medicine Nabs Five-Year VA Contract for Tumor Molecular Profiling of Cancer Patients
The national contract covers FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme.
VA Aims to Automate Input of Pharmacogenomic Data Into EHR, Studying Impact of Recommendations
Premium
Researchers are taking steps to refine and scale the VA's National Pharmacogenomics Program, an extension of the PHASER pilot.
In the next decade, the MVP is looking forward to using its cache of data on 1 million veterans to better understand and address health disparities.
Biofidelity, Fidelis Partner to Supply ASPYRE-Lung Test to VA Medical Centers
The distributor will market Biofidelity's lung cancer biomarker test to its network of VA and active US military institutions.
May 31, 2023
Mar 31, 2023
Jul 11, 2019
Mar 12, 2019